United States · Venture startup
9 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.2Mraised across 9 rounds since 2009, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
National Institutes of HealthFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Galectin Therapeutics's investors include 10X Fund LP and National Institutes of Health.
Galectin Therapeutics has raised $8.2M across 9 rounds since 2009.
Galectin Therapeutics's most recent round was a Venture of $3.0M in Jan 2011.
Its most recent round, $3.0M in Jan 2011, is also its largest on record.
Galectin Therapeutics's first round on record, in Feb 2009, was backed by 10X Fund LP.
Galectin Therapeutics's latest named round is a Venture, in Jan 2011.
Galectin Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·